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12-0-Tetradecanoylphorbol a cetate (TP A) applied to 
mouse ears rapidly induces an edema which is maximal 
by 6 hr but has subs tantially waned by 24 hr. (This is in 
contrast to many inflammatory agents that cause a pro-
longed edema lasting many days.) Reapplication of TP A 
at 16-24 hr will not provoke a second ed ematous re-
sponse although increased erythema is evident. Arachi-
don ic a cid (AA) applied to mouse ears (4 mg) provoke s 
an even more rapid edema which is maximal at 1 hr and 
has substantially waned by 6 hr. R eapplication of AA at 
3-24 hr also will not provoke a second ed ematous re-
sponse although, again, incre ased erythema does result. 
Pretreatment of ears with AA r esults in inhibition of the 
edema r esponse to subsequent application of TPA, and 
TPA pretreatment moderately inhibits a subsequent r e-
sponse to AA. TP A-induced edema can be d elayed by 
agents such a s naproxen, an inhibitor of AA cyclooxy-
genase. In co'ntras t, AA-induced ed ema is inhibited only 
by a gents , s uch as phenidone, that inhibit both cycloox-
ygenase and lipoxygenase . The data suggest that the 
edemas r esult from inte r a ction of the products of the 
cyclooxygenase and lipoxygenase pathways of AA m e-
ta bolism. The la ck of secondary edema r esponse appears 
to be related to the ina bility of TP A or AA to reinduce 
vascular p ermeability. The effect is sp ecific to AA and 
TP A; r esponses to xylen e or anthralin are unaffected by 
TPA or AA pretreatment. It is postulated that the tach-
yphyla ctic e ffects observed involve lipoxygenase m e-
tabolites of AA, 
In t he search for novel th e ra peut ic agents useful in th e topical 
t reatment of inflammatory skin condit ions, considera ble em -
phasis must be p laced on t he rou t ine screening of compounds 
in animal models . With respect to known classes of agents such 
as topical corticosteroids whose m echa nism of action is fa irly 
well understood [1] a nd whose clinical effi cacy is virtually 
guaranteed, a ny animal m odel y ielding r elative potency esti-
mates serves well [2], al though occasional pi tfalls are en coun-
te red [3]. U nd er this circums ta nce we ar e not normally con-
cerned with t he mechanisms involved in the model inflamma-
t ion, nor even with the r elevance of the model to human skin 
inflammation . H owever , wi t h respect to novel agents, whose 
efficacy a nd m echanism of action a re unkn own, the relevance 
and proper t ies of the animal model must be give n due cons id-
eration so t hat false-posit ive or negative resul ts do not lead us 
too fa r astray. 
One of the more commonly used animal models is that of 
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roden t ear edema induced by a pplication of cro ton oil [2] or its 
active constituent 12-0-tetradecanoylphorbol acetate [4]. T his 
latter compound, TP A, is unde r active investigation as a tumor 
promoter , as an inducer of epiderma l hyperplasia, a nd as an 
effec tor or actuator in a mult itude of in vi tro systems. The 
processes involved in t he induction of inHammation by topical 
application of this compound ar e no t well unde rstood, al th ough 
th e M erck group [5] h as am assed considera ble evidence t hat 
elevated levels o f the hydroperoxy end operoxide, PGG2, form ed 
from arachidonic acid (AA) , a re associ.ated with edem a induc-
tion. 
Our own inte rest in t he m ech anisms involved in TPA-induced 
infla mmation was stimulated by th e a bove considerations, as 
well as th e observa tion that TP A-induced ear edem a was s hor t -
lived in comparison wi t h that induced by other phlogistic agents 
such as retinoic acid , oxazolone, and a nthra lin. While T P A-
induced edem a could be prolonged by using higher doses, 
reapplication of the usua l dose of 1 Ilg/ ear , a fte r a 24-hr in te rval, 
did not resul t in reinduction of edem a. We repor t h ere our 
studies on a phenomenon which we interpret as a s pecific 
tachyphylaxis to induction of vascular leakage which m ay in-
volve products of AA me ta bolism . 
48 
MATERIALS AND METHODS 
Anim als 
Female Swiss Webster mice, 5-8 weeks old, were obta ined from 
Simonsen Labs, Gilroy, Ca lifornia and held under standru'd conditions 
for 1 week prior to use, wi th food and water ad lib. Animals were 
randomly assigned to treatment groups of 8, housed together in a cage. 
Chemica.ls 
12-0-Tetradecanoyl phorbol acetate was from Chemical Ca rcinogens, 
Eden Prairie, Minnesota; anthralin (USP, > 95%) from City Chemical 
Corp., New York, New York; all -trans- retinoic ac id, ru'achidonic acid, 
and oxazolone from Sigma Chemical Co., SL. Louis, Missouri. Com-
pounds were prepared as solu tions in reagent-grade acetone just prior 
to application. 
Trea.lmenls 
Test materials dissolved in acetone were de livered to the right ears 
only of mice by means of an automatic microliter pipet. Volumes of 10 
II I were delivered to each of the inner and outer surfaces of the ear . 
This volume spread evenly over the whole surface of the ear with 
minimal drainage to the base and onto the skull and neck. 
Edem a Measurements 
For ear thickness determinations, an Oditest dial caliper gauge, 0-0.8 
inches, wi th gradations of 0.001 inches modified to increase the contact 
surface ru'ea and reduce the tension, was applied to the tip of the eru·. 
Ear 'thickness was recorded in uni ts orO.OOl inches. In order to minimize 
variation due to technique, measurements throughout an experiment 
were performed by a single investigator. This method allows edema 
development in individual animals to be followed tl1l'ough time wi thout 
the need for anesthesia. In order to provide a more objective assessment 
of edema at critical time poin ts, appropriate experiments were repeated 
in which groups of animals were killed by cervical dislocation, the ears 
immediately removed wi th sharp scissors, and 8 mm diameter plugs 
were obtained from the tip with a biopsy punch. The plugs were 
immediately weighed to the nearest 0.1 mg. In both cases, the means 
± standard deviation were calculated for each treatment group (N = 
8). 
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Histologic Pmcedures 
At appropriate in terva ls after applicat ion of the inf1a mmatory agents, 
ears from groups of 4 mice were removed , f'ixed in neutra l buffered 
forma lin, paraffin embedded a nd sectioned at 7 /lm. Slides were tained 
wit,h hematoxylin-eos in or with Wright's buffered different ia l s ta in . 
HESULTS 
Comparative Time Course of TPA-Induced Ear Edem a 
When 1 !J.g TP A is applied to the ears of mice, vasodilatation 
becomes apparent by 1.5 nr, a nd edema max imizes at 6 hI', 
waning thereafter to nea r contro l levels at 24 hI' (Fig 1). Al-
though the edema has substantially resolved at 24 hI', t he ea rs 
are still visibly vasodil ated and hyperemic, as shown prev iously 
by H ecker et al [6]. Inflammatory cells are still present at 24 
a nd 48 hr (Table I). T his ra pid resolu tion of edema in the TPA-
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F IG l. Time l:ourse of mouse ear edema response to topica lly applied 
agents. Th e agent.s we re applied in 20 /ll acetone at doses of: TPA, J 
/lg (e); oxazolone, 1 mg (0 ); a nth ra lin, 200 /lg (0), and retinoic acid, 200 
/lg (.6.). Th e oxazolone response was obtained in animals sensit ized by 
prior topical a pplication to abdominal skin. 
TABL" 1. Histologic Examin a.tion of In/lammatory Ear R eactions to 
TPA and toM 
Hours post 
appli cation 
3 
24 
48 
TPA, I I(g/enr 
S light vasodilatation 
Ma rked vasodi lat,ation, 
var iable dermal 
edema 
[nf1ammato ry ce lls in 
vessels and t issue 
Vessels d ilated a nd oc-
cluded with inna m-
matory ce lls 
Ma rked edema a nd ce ll 
infi ltrat,e in dermal 
in terstit ium 
Vasod ilatation, s light 
edema 
Masses of degenerating 
ce lls in dermis 
Epidermal mi toses and 
mild hyperplasia 
Cell infiltrate in dermis 
still marked 
Occasional epidermal 
abscesses 
Modera t,e t,o marked 
epidermal hyperpla-
s ia 
AA. <I mg/ em' 
Marked vasodilatation, der-
ma l edema 
[nHa mmatory ce lls in vesse ls 
and tissue 
Ma rked vasod ilat.ation, slight 
reduction in de rmal edema 
Decrease (?) in cellula r infil-
trate 
S ubstant ia l redu ction of' 
edema and ce ll infiltrate 
compa red with 1 hr 
S ligh t vasodilatation, minimal 
edema 
Infrequent accumulations of 
inna mmatory ce lls beneath 
stratum corneum 
Frequent epiderma l mi toses 
but minimal hyperplasia 
Infla mmatory ce lls absent 
Frequent epidermal mi toses 
bu t only sligh t hyperplasia 
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FI G 2. Mouse ear edema response to TPA, 1 fLg (e ) or a nthra lin, 
200/lg (0 ) 24 hr aft.er ini tia l application of 1 fLg TPA. Vertical bars 
indicate standa rd deviations of treatment. groups differing with a sig-
nifica nce of p < 0.05 or bet te r. 
inflamed ear is dose dependent since a pplication of 10 {lg/ ear 
results in a much prolonged response and eventual necrosis. 
Doses lower than 1 !J.g produced consistently less edema, with 
the threshold of detectable edema OCCUlTing at 0.1 !J.g. This is in 
contrast to the much lower doses that produce erythema but 
no edema [6]. Conseq uently, unless otherwise stated, all appli-
cations of TPA were made at t he 1 !J.g/ ear level. 
In contrast to the inflammatory reactions produced by an-
thralin, retinoic acid, or oxazolone in sensitized a nimals (Fig 1) 
the response to TPA appear ed to be pecul iarly shor t-lived, at 
least wi th respect to edema. 
Ta.chyphylaxis to R epeat Applications of TPA 
In view of the short-lived edema response to a single appli-
cation of TP A, several attempts were made to boost or pro long 
the response by reapplying TPA between 16 a nd 24 h1'. Al-
though ears t reated with TPA 24 hr previously (Fig 2) showed 
residua l edema and erythema, reapplication of TPA resulted in 
increased vasod ilatation and erythema bu t substantially less 
edema than anticipated. T his tachyphylax is appeared to be 
specific to TPA since application of the unrelated agents, a n-
thralin (Fig 2) or xylene (not shown) , resul ted in return of 
maximal edema. 
The tachyphylactic response to TPA was examined wit h 
respect to dose and t ime as shown in Fig 3. Ears were initia lly 
treated wi th either the optimal dose (1 !J.g) or the threshold 
dose (0.1 !J.g) of TPA and t hen t reated with 1 !J.g TPA at 24 hI' 
(Fig 3A ). Animals initially receiving the t hreshold dose re-
sponsed maximally to the second dose; a nimals ini t ially receiv-
ing t he optimal dose of TPA responded minimally . In a series 
of experiments using initial doses of 0.1-2 !J.g TPA, t he edema 
response to 1 flg TPA at 24 h I' was inversely proportional to the 
amount of edema produced by the fir ~ dose. 
If the second a pplication of TP A was delayed until 48 hI' (Fig 
3B) , maximal edema, not tachyphylaxis, was observed. When 
ears were treated sequentially with TPA at 0,24, a nd 48 hI' (Fig 
3C ), maximal edema was produced after t he t hird dose in spite 
of t he fact t hat these sam e a nima ls had failed to respond to t he 
second dose at 24 hI'. 
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FIG 3. Mouse ear edema responses to repeated application of TPA. 
A , Ears were treated with OJ. Jlg (~) 01' 1 Jlg (e) TPA at 0 h1', and 1 Jlg 
TPA was applied at 24 hr. Band C, Afler the ini tial dose of 1 Jlg TPA, 
ears were treated with either l/lg TPA (e) or acetone (0 ) at the limes 
indicated by the arrowtl. 
Arachidonic Acid-Induced Ew: Edema 
In order to explore the role of AA release and metabolism in 
TPA-induced edema and subsequent tachyphylaxis, the effects 
of topical application of prostaglandins a nd AA on the mouse 
ear were examined. At doses of 10-40 p.g/ear, PGE , and PGE2 
caused marked vasod ilatation within 30 min, but the ears did 
not become edematous; PGF2" had no observable effect. Pre-
treatment of ears with these prostaglandins did not alter the 
inf1ammatory reaction produced by TP A. 
When AA was applied at 40 p.g/ear, an intense vasodilatation 
and erythema were observed within 5 min, but again no edema 
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developed (Fig 4). However , when the applied dose was in-
creased to 0.4 mg and 4 mg, a threshold and maximal edem a, 
respectively, were produced (Fig 4). The nota ble feature of AA-
induced edema was the rapidity of onset and the even more 
rapid waning compared with TP A. Because of the high dose of 
AA used , it was necessary to demonstrate that nonspecific toxic 
effects were minimal . The resu lts of histologic studies compar -
ing AA- with TPA-induced inflammation are given in T able 1. 
One hour after AA application, ear sections showed vasodila-
tation, derma l edema, and masses of polymorphonuclear and 
large mononuclear cells, not only in blood vessels, bu t already 
in the dermal interstitium. By 3 hr the number of inf1ammatory 
cells appeared to be decreased although this could not be 
quantitated because of the reduction in edema. At 6 hI', the 
reduction in edema and cellular infiltrate were obvious. During 
this period no epidermal changes suggestive of necrosis were 
detected . By 24 and 48 hI', it was difficult to find a ny inf1a m-
matory cells; epidermal mitoses were frequent, but by compar-
ison with TPA-treated ears there was little, if a ny, epidermal 
hyperplasia. By comparison, oleic acid at 20 mg/ear produced 
a slight ear reddening, but no significant edema over a 48-h1' 
observation period. 
Arachidonic Acid-Induced Tachyphy laxis 
Since AA appeared to mimic the inflammatory effects of 
TPA, but with an accelerated time course, the effect of AA 
pretreatment on TPA-induced edema was examined. When AA 
(4 mg/ear) was applied 2 h1' prior to TPA (Fig 5A), the response 
to the latter was moderately but significantly diminished . If the 
time between AA a nd TPA treatments was extended to 20 11.1' 
(Fig 5C), suppression of TPA-induced edema was virtua lly 
complete. As shown in the previous experiments (Fig 3A), the 
degree of tachyphylaxis induced by AA is dependent on the 
dose used initially . When ears were pretreated with a subopti-
mal dose of AA (1 mg/ear) , only partial inhibition of TPA-
induced edema OCCUlTed (Fig 5C). 
Arachidonic acid was found to be very effective in causing 
tachyphylaxis to itself. In a series of t ime course experiments, 
unresponsiveness to a second application of AA could be dem-
onstrated over the interval of 2-30 hI'. Figure 6 illustrates the 
complete suppression of AA-induced edema 24 hI' after the 
ini tial application. At this time, the AA-pretreated ears show a 
slight r esidua l erythema and they become intensely erythema-
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FIG 4. MOllse ear edema response to doses of topically applied AA. 
Ears treated with 0.04 mg (0 ) showed marked vasodilatation. 
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(0 ) received acetone prior to TPA treatment. 
tous in response to the second AA application. Aga in, the effect 
is fail'ly specific since both xylene and antl11'alin ar e capable of 
inducing edema in AA-pretreated ears. 
In order to determine whether the tachyphylaxis was a local 
or systemic effect, a series of experiments was performed in 
which mice received an ini t ia l dose of AA on either t he left or 
t he right eal'. At intervals between 2 and 24 hI', all groups 
including appropria te acetone controls were dosed a second 
time on the right ears only. In every case, t he effect was 
observed to be entirely local; pretreatment of the right ear had 
no effect on the subsequent response of the left ear. 
Effect ofTPA Pretreatment on AA-Induced Edema 
In a series of experiments in which TPA-pretreated ears were 
dosed wit h AA 16-24 hr la ter, there was a consistent and 
significant depression of the expected AA response, bu t t he 
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tachyphylaxis was less dramatic t han in t he previous cases. 
S ince TPA-treated ears still show significant bu t reduced edema 
up to 24 hI', the question al'ises as to what th e appropriate 
control groups should be. If acetone- and TPA-pretreated ears 
are compared for their response to AA, significant tachyphy-
laxis amount ing to about 30% was observed in only 2 out of 3 
ex periments and inhi bit ion was restricted to measw-ements 
made 30 and 60 min after AA application. The resul ts could be 
in terpreted as a delay a nd t hen prolonged response to AA in 
TPA-pretreated anima ls. However, if comparisons were m ade 
to a nima l groups which were TP A pretreated a nd t hen acetone 
dosed, thLls taking in to account t he residua l TPA-induced 
edema, TPA pretreatment appeared to produce a 40-60% re-
duction in t he subsequent response to AA over observation 
periods of LIp to 6 lu·. 
E ffect of Nonsteroidal Antiinflammatory Agents on TPA-
and AA-Induced Edema 
S ince t he a bove resul ts suggested that AA release a nd sub-
sequent metabolism were important in the observed phenom-
ena and since it had been shown that TPA-induced edema 
could be prevented by nonsteroidal a ntiinflammatory agen ts 
[4,7,8], we examined several agents for their effects on both 
TPA- a nd AA-induced edema. While we have not confirmed 
the specificity of action in the mouse ear , the agents were 
chosen based on li terature reports of relative inhibitory activity 
against arachidonate cyclooxygenase and lipoxygenase. N a-
proxen and indomethacin are relatively specific inhibitors of 
cyclooxygenase [9] although inhibit ion of peroxidase [10] ha 
recently been reported. In contrast, nordihyd}'oguaiaretic acid 
[11] and phenidone [9] inhibit both cyclooxygenase a nd lipox-
yge nase, wi th sligh t specificity fo r the latter. These relative 
specificities have been confirm ed at least for mouse epidermal 
homogenates [12]. 
As can be seen in T a ble II, TPA-induced edema is s ignifi-
cantly inhibited by all 4 agents, although the degree of inhibi-
tion is dependent on the t ime of measuremen t. Thus, for 
example, naproxen delays the onset of maximal edem a, bu t 
under the conditions described this apparent inhibition disap-
pears with t ime. It should be noted that these inhibi tory effects 
are observed only if the compounds are applied within 30 min 
before or after TP A. While an exhaustive pharmacologic anal-
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FIG 6. Mouse ear edema response to 20 Jll xylene or 4 mg AA in 
acetone applied 24 hI' after ini tial treatment with AA. 
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TABLE II. InhibitolY Effects of Anti-inflam.m.atOlY Agents on TPA-
and AA-Induced Edema 
% Inhibi tion of ear plug weight 
Compound Dose/ea r TPA edema " (l11g) AA edema " 
4 hI' 6 hI' 8 hI' 
Napl'oxen 2 61 43 33 0 
1 35 
0.5 21 
T ndomethacin ,. 2 42 24 d 
I 37 
0.5 11 
Nordihydroguaial'etic 2 36 55 50 43 
acid 1 l4 9 
Phenidone 2 59 27 31 63 
1 63 
0.5 26 
"Compounds were applied 15 min afte r TPA; ear plug weights were 
determined at t imes indicated after TPA. 
"Compounds were applied 30 min before AA; ear plug weights we re 
de te rmined 1 hI' a fter AA. 
,. Tested aga inst a TPA dose of 2.5 /lg/ear. 
d In 2 repetitions of th is assay, inhibitions of 17% and 27% were 
obta ined, but neither was significant (p > 0.05) . 
ysis of the TP A inflammation is beyond t he scope of this paper, 
the resul ts are consistent with a major role for AA metabolites 
in the production of edema. 
Neither naproxen nor indomethacin were consistently active 
in the AA-induced edema, although t he vasodi la tation a nd 
erythema at 15 min were partially suppressed. Significant in-
hibi tion of AA-induced edema could be achieved only with 
agents that possessed both cyclooxygenase a nd lipoxygenase 
inhibi tory activity, as exemplified by phenidone a nd nordihy-
droguaiaretic acid . 
DISCUSSION 
The rapid resolution of TPA-induced ear edema in compari-
son with other model inflammations s timulated our investiga-
t ion of t he possible mechanisms involved . The demonstration 
of a spec ific unresponsiveness with respect to edema induction 
suggested either a depletion of inflammatory mediators or a 
tachyphy laxis to such mediators. On the basis of the following 
considerations it appeared that AA meta bolites might be in -
volved in edema induction by TPA as well as the subsequent 
resolution a nd unresponsiveness: (1) For both in vivo [13,14] 
a nd in vitro [15,16] situations, TPA causes the release from 
phospholip id pools and subseq uent m etabolism of AA. (2) TPA-
induced ea r edema can be inhibited 01' at least modified by 
agents whose presumed mechanism of action is inhibition of 
AA metabolism [7,8]. 
The demonstration that topically a pplied AA induced a n 
even, more a brupt and short-lived edema followed by a specifi c 
unresponsiveness to both AA a nd TPA provides strong support 
for the rol e of AA metabolites in these phenomena. Even 
though relatively high doses of AA were used in this study, 
histo logic a nd gross observations exclude nonspecific toxi city 
effects. While the participation of other inflammation mediators 
cannot be excl uded at. this time, recent observations conce rning 
the actions of various a rachidonate metabolites provide t he 
basis for a tentative expl1;l nation of ou r results. 
In t he ear reaction to TPA, vasodilatation is apparent within 
1-2 hI' a nd lasts for as long as 48 hr. This is consistent with an 
early [13] and prolonged [14] production of vasodilatory pros-
taglandins, as shown for mouse dorsal skin after TPA treatment. 
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The increase in erythema in response to reapplication of TP A 
or AA is consistent with stimulation of prostaglandin produc-
tion to even greater leve ls. Prostaglandins (and PGU do not by 
themselves cause edema, but by increasing blood now they 
enhance the effects of' agents causing vascular permeability 
such as complement-derived products, bradykinin [17) and the 
leukotrienes [18,19]. The tachyphylactic effects which we have 
described are related to vascular permeabili ty changes and not 
to vasodilatation or blood now changes. Further studies are 
needed to determine which mediators of vascular permeabili ty 
are involved in the TPA- and AA-induced ear edemas and 
whether the effects observed are the result of mediator deple-
t ion or a true tachyphylaxis. In view of the inhibitory effects of 
phenidone and nordihydroguaiaretic acid on both inflamma-
tions (Table II), we are proceeding on the assumption that 
lipoxygenase products are responsible for inducing vascular 
leakage in these instances. 
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